$38.27
-$0.16
(-0.40%)
Quote as of 3:06 PM EST on 02/09/12
Merck & Co., Inc.
NYSE:MRK
|
$38.27
-$0.16
(-0.40%)
|
|
| Today's Open | $38.39 |
|---|---|
| Previous Close | $38.42 |
| Daily Range | $38.14 - $38.52 |
| 52-Week Range | $29.47 - $39.43 |
| Market Cap | $116.63B |
| P/E Ratio | 19.02 |
| Dividend (Yield) | $1.68 (4.4%) |
| Ex-Dividend Date Dividend Pay Date |
12/13/11 01/09/12 |
| Volume | 5,710,940 |
| Average Daily Volume | 13,275,362 |
| Current FY EPS | $3.80 |
MRK Information
| Description |
|---|
| A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. |
| Sector |
| Healthcare |
| Industry |
| Pharmaceuticals |
News & Commentary
Here's 1 Reason Merck Looks Weak
YCHARTS DIVIDEND DAILY: Some “Non-Royalty” Dividends Beat the Aristocrats
Why the Dow's Flat This Morning
Higher Bleeding Haunts Merck Candidate - Analyst Blog
Modified Study, Same Bloody Results
Buy, Sell, or Hold: Ariad Pharmaceuticals
Merck: Vorapaxar Reduced Heart Attack Risk, But Raised Bleeding Risk
UPDATE: Merck Anti-Clotting Drug Meets Study Goal But Has Bleeding Risk
Is This Situation Special Enough?
Merck Investors Can Sleep Easier (Not Easy)
